Laura Lupi

TL;DR: This case report describes an otherwise healthy 53-year-old woman who tested positive for CO VID-19 and was admitted to the cardiac care unit in March 2020 for acute myopericarditis with systolic dysfunction, confirmed on cardiac magnetic resonance imaging, the week after onset of fever and dry cough due to COVID-19.

TL;DR: Hospitalized patients with concomitant cardiac disease and COVID-19 have an extremely poor prognosis compared with subjects without a history of cardiac disease, with higher mortality, thrombo-embolic events, and septic shock rates.

TL;DR: The majority of AM occurs in the absence of pneumonia and is often complicated by hemodynamic instability, with an outcome that differs on the basis of the presence of concomitant pneumonia.

TL;DR: The literature data about predictors of atrial fibrillation recurrence are highlighted, with special regard to clinical, therapeutic, biochemical, ECG and echocardiographic parameters after electrical cardioversion and ablation.

TL;DR: A COAPT-like profile, including specific echocardiographic and clinical criteria, identifies patients with SMR who have a better prognosis after MitraClip implantation and was an independent predictor of long-term outcomes.